The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nextmune concentrate and solvent for suspension for injection for chickens

CEVA-Phylaxia Veterinary Biologicals Co. LtdVPA10463/009/001

Main Information

Trade NameNextmune concentrate and solvent for suspension for injection for chickens
Active SubstancesLive attenuated IBD virus, serotype 1, strain G-61
Dosage FormConcentrate and solvent for suspension for injection
Licence HolderCEVA-Phylaxia Veterinary Biologicals Co. Ltd
License Holder Address1107 Budapest
Szállás u. 5.
Licence NumberVPA10463/009/001

Group Information

ATC CodeQI01AD09 avian infectious bursal disease virus (gumboro disease)
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued07/08/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back